iShares Genomics Immunology and Healthcare ETF
Price through Oct 26, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 26, 2026. Holdings snapshot retrieved Oct 26, 2026.
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
IDNA price
Table
| Date | IDNA close |
|---|---|
| Jul 27, 2026 | $32.24 |
| Jul 28, 2026 | $32.45 |
| Jul 29, 2026 | $32.15 |
| Jul 30, 2026 | $32.79 |
| Jul 31, 2026 | $32.33 |
| Aug 3, 2026 | $32.42 |
| Aug 4, 2026 | $32.91 |
| Aug 5, 2026 | $33.34 |
| Aug 6, 2026 | $33.58 |
| Aug 7, 2026 | $34.78 |
| Aug 10, 2026 | $35.26 |
| Aug 11, 2026 | $35.20 |
| Aug 12, 2026 | $35.42 |
| Aug 13, 2026 | $35.24 |
| Aug 14, 2026 | $35.23 |
| Aug 17, 2026 | $35.86 |
| Aug 18, 2026 | $35.98 |
| Aug 19, 2026 | $40.75 |
| Aug 20, 2026 | $39.29 |
| Aug 21, 2026 | $40.08 |
| Aug 24, 2026 | $39.67 |
| Aug 25, 2026 | $41.48 |
| Aug 26, 2026 | $40.63 |
| Aug 27, 2026 | $40.60 |
| Aug 28, 2026 | $39.29 |
| Aug 31, 2026 | $39.26 |
| Sep 1, 2026 | $39.67 |
| Sep 2, 2026 | $40.20 |
| Sep 3, 2026 | $40.29 |
| Sep 4, 2026 | $39.77 |
| Sep 8, 2026 | $39.23 |
| Sep 9, 2026 | $38.60 |
| Sep 10, 2026 | $37.88 |
| Sep 11, 2026 | $38.06 |
| Sep 14, 2026 | $38.74 |
| Sep 15, 2026 | $38.59 |
| Sep 16, 2026 | $38.70 |
| Sep 17, 2026 | $40.00 |
| Sep 18, 2026 | $39.83 |
| Sep 21, 2026 | $40.63 |
| Sep 22, 2026 | $41.74 |
| Sep 23, 2026 | $40.78 |
| Sep 24, 2026 | $41.69 |
| Sep 25, 2026 | $41.77 |
| Sep 28, 2026 | $41.79 |
| Sep 29, 2026 | $42.63 |
| Sep 30, 2026 | $42.32 |
| Oct 1, 2026 | $41.64 |
| Oct 2, 2026 | $41.65 |
| Oct 5, 2026 | $42.72 |
| Oct 6, 2026 | $40.87 |
| Oct 7, 2026 | $40.88 |
| Oct 8, 2026 | $40.42 |
| Oct 9, 2026 | $42.17 |
| Oct 12, 2026 | $41.56 |
| Oct 13, 2026 | $40.79 |
| Oct 14, 2026 | $41.28 |
| Oct 15, 2026 | $42.05 |
| Oct 16, 2026 | $40.54 |
| Oct 19, 2026 | $40.96 |
| Oct 20, 2026 | $42.58 |
| Oct 21, 2026 | $42.70 |
| Oct 22, 2026 | $41.04 |
| Oct 23, 2026 | $40.91 |
| Oct 26, 2026 | $40.95 |
Weekly net flows, 3M
Net inflow over the range: +$79M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Jul 27 | $2.7M |
| Aug 3 | −$2.7M |
| Aug 10 | $7M |
| Aug 17 | $6M |
| Aug 24 | $12.3M |
| Aug 31 | $2M |
| Sep 7 | $5.7M |
| Sep 14 | $1.9M |
| Sep 21 | $2M |
| Sep 28 | $25.2M |
| Oct 5 | $6.4M |
| Oct 12 | $0 |
| Oct 19 | $10.3M |
| Oct 26 | $0 |
Money keeps arriving — +$42M of net inflows over the past month, about 13.1% of the fund's asset base, while the price has returned +56.4% so far this year. At 0.47% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 12.14% | $198.85 | -0.6% | ||
| 2 | TWSTTWIST BIOSCIENCE | 5.82% | $145.25 | +3.8% | ||
| 3 | GSKGSK | 2.81% | $51.10 | +0.7% | ||
| 4 | IOVAIOVANCE BIOTHERAPEUTICS | 4.94% | $13.78 | -2.2% | ||
| 5 | REGNREGENERON PHARMACEUTICALS | 3.65% | $807.67 | +0.3% | ||
| 6 | CAICaris Life Sciences | 3.54% | $32.45 | +1.4% | ||
| 7 | EXELEXELIXIS | 3.52% | $65.11 | +0.9% | ||
| 8 | RVMDREVOLUTION MEDICINES | 3.61% | $183.90 | -1.7% | ||
| 9 | MRKMERCK & CO | 3.46% | $140.61 | -3.2% | ||
| 10 | VRTXVERTEX PHARMACEUTICALS | 3.37% | $517.49 | -1.2% | ||
| 11 | INCYINCYTE | 3.25% | $113.31 | -2.1% | ||
| 12 | ROPROPER TECHNOLOGIES | 3.31% | $441.65 | +0.8% | ||
| 13 | BNTXBIONTECH SE | 2.88% | $86.86 | -1.4% | ||
| 14 | IBRXIMMUNITYBIO | 2.79% | $7.81 | -5.0% | ||
| 15 | ABCLABCELLERA BIOLOGICS | 2.50% | $12.08 | +2.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 63Sector weights
- Health Care99.75%
- Cash and/or Derivatives0.24%
Show as table
| Item | Value (%) |
|---|---|
| Health Care | 99.75% |
| Cash and/or Derivatives | 0.24% |
Country weights
- United States66.72%
- Germany6.27%
- France5.7%
- Japan5.49%
- Denmark4.63%
- Switzerland3.32%
- United Kingdom2.83%
- Canada2.5%
Show as table
| Item | Value (%) |
|---|---|
| United States | 66.72% |
| Germany | 6.27% |
| France | 5.7% |
| Japan | 5.49% |
| Denmark | 4.63% |
| Switzerland | 3.32% |
| United Kingdom | 2.83% |
| Canada | 2.5% |
| 1 week | -3.8% |
| 1 month | -2.0% |
| 3 months | +27.8% |
| 6 months | +36.6% |
| YTD | +56.4% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$10M |
| 1 month | +$42M |
| 3 months | +$79M |
| YTD | +$108M |
| 1 year | +$107M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct | $1.3M |
| Nov | −$5.2M |
| Dec | $4M |
| Jan | $0 |
| Feb | $3.1M |
| Mar | $3M |
| Apr | $7.7M |
| May | $0 |
| Jul | $18.3M |
| Aug | $22.6M |
| Sep | $20.1M |
| Oct | $33.6M |
The top holding is 12.1% of the book; the top ten carry 49%. Spread across 53+ names, it behaves like roughly 24 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $52M | $70M |
| MRK MERCK & CO | $4M | $5M |
| JANX JANUX THERAPEUTICS | $2M | $2M |
| IOVA IOVANCE BIOTHERAPEUTICS | $1M | $2M |
| VRTX VERTEX PHARMACEUTICALS | $1M | $454,914 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IDNA on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $40.7B | +$609M | -44bp on fee · 127× the assets · +$609M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -44bp on fee · 57× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -43bp on fee · 101× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$51M | -43bp on fee · 74× the assets · +$51M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -43bp on fee · 58× the assets · +$412M in over the month | Head-to-head |